bioRxivImmunologyPreprint
C-terminal truncation of CXCL10 attenuates inflammatory activity but retains angiostatic properties
L. Dillemans, K. Yu, A. De Zutter, S. Noppen, M. Gouwy, N. Berghmans, M. De Bondt, L. Vanbrabant, S. Brusselmans, E. Martens, D. Schols, P. E. Marques, S. Struyf, P. Proost
Abstract
Interferon-{gamma}-inducible protein of 10 kDa (IP-10/CXCL10) is a dual-function CXC chemokine that coordinates chemotaxis of activated T cells and natural killer (NK) cells via interaction with its G protein-coupled receptor (GPCR), CXC chemokine receptor 3 (CXCR3). As a consequence of natural posttranslational modifications, human CXCL10 exhibits a high degree of structural and functional heterogeneity. However, the biological effect of natural posttranslational processing of CXCL10 at the carboxy (C)-terminus has remained partially elusive. The truncated CXCL10 proteoform CXCL10(1-73), lacking the four endmost C-terminal amino acids, was previously identified in human cell culture supernatant. To further explore the functioning of CXCL10(1-73), we optimized its production in this study through Fmoc-based solid phase peptide synthesis (SPPS) and propose an SPPS strategy to efficiently generate human CXCL10 proteoforms. Compared to intact CXCL10(1-77), CXCL10(1-73) had diminished affinity for glycosaminoglycans including heparin, heparan sulfate and chondroitin sulfate A. Moreover, CXCL10(1-73) exhibited an attenuated capacity to induce CXCR3A-mediated signaling, as evidenced in calcium mobilization assays and through quantification of phosphorylated extracellular signal-regulated kinase-1/2 (ERK1/2) and protein kinase B/Akt. Furthermore, CXCL10(1-73) incited reduced primary human T lymphocyte chemotaxis in vitro and evoked less peritoneal ingress of CXCR3+ T lymphocytes in mice receiving intraperitoneal chemokine injections. In contrast, loss of the four endmost C-terminal residues did not affect the inhibitory properties of CXCL10 on spontaneous and/or FGF-2-induced migration, proliferation, wound healing, phosphorylation of ERK1/2, and sprouting of human microvascular endothelial cells. Thus, C-terminally truncated CXCL10 has attenuated inflammatory properties, but preserved anti-angiogenic capacity. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/548382v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@10c1207org.highwire.dtl.DTLVardef@173bc5eorg.highwire.dtl.DTLVardef@153d6a2org.highwire.dtl.DTLVardef@1302a76_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action
C. W. White, L. E. Kilpatrick, … S. J. Hill·bioRxiv·Jul 5, 2021
- IFNγ induces epithelial reprogramming driving CXCL11-mediated T cell migration
Alessandro Cutilli, Suze A Jansen, … Paul J Coffer·bioRxiv·Feb 3, 2024
- CXCL10/CXCR3 Signaling Induces Neural Senescence and Cognitive Impairments
Monika Patel, Sakesh Kumar, … Prem Narayan Yadav·bioRxiv·Oct 16, 2024
- Basal Internalization and Subcellular Localization of XCR1
Qiao Li, Fabian Pfersdorf, … Martin B Gustavsson·bioRxiv·Jun 30, 2026
- Rules of engagement: determinants of chemokine receptor activation and selectivity by CCL27 and CCL28
Mian Huang, Aura F. Celniker, … Tracy M. Handel·Journal of Biological ChemistryPeer-reviewed·Sep 19, 2025
- Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma
Cheyanne K. Shinn, Robert Saddawi‐Konefka, … Tracy M. Handel·bioRxiv·Apr 24, 2025